- Home
- Publications
- Publication Search
- Publication Details
Title
Economies of resistance
Authors
Keywords
-
Journal
Critical Public Health
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2023-10-25
DOI
10.1080/09581596.2023.2271140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Investment and quality competition in healthcare markets
- (2022) Ziad Ghandour et al. JOURNAL OF HEALTH ECONOMICS
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- (2022) Christopher JL Murray et al. LANCET
- How pharmaceutical and diagnostic stakeholders construct policy solutions to a public health ‘crisis’: an analysis of submissions to a United Kingdom House of Commons inquiry into antimicrobial resistance
- (2022) Rebecca E. Glover et al. Critical Public Health
- The administration of harm: From unintended consequences to harm by design
- (2022) Alex Broom et al. CRITICAL SOCIAL POLICY
- Vulnerability and antimicrobial resistance
- (2022) Alex Broom et al. Critical Public Health
- The modern hospital executive, micro improvements, and the rise of antimicrobial resistance
- (2021) Alex Broom et al. SOCIAL SCIENCE & MEDICINE
- Antibiotic resistance, planetary health and the mimetic trap: a historical account of present-day sanitary, environmental and social crises
- (2021) Flavio D’Abramo Postcolonial Studies
- Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance
- (2021) Vance G Fowler et al. CLINICAL INFECTIOUS DISEASES
- Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement
- (2021) Daniel Berman et al. Lancet Global Health
- NIMble innovation—a networked model for public antibiotic trials
- (2021) Rebecca E Glover et al. Lancet Microbe
- The inconvincible patient: how clinicians perceive demand for antibiotics in the outpatient setting
- (2019) Mike R Kohut et al. FAMILY PRACTICE
- A governance framework for development and assessment of national action plans on antimicrobial resistance
- (2019) Michael Anderson et al. LANCET INFECTIOUS DISEASES
- (Inter)nationalising the antibiotic research and development pipeline
- (2019) Andrew C Singer et al. LANCET INFECTIOUS DISEASES
- Antimicrobial Resistance: Implications and Costs
- (2019) Porooshat Dadgostar Infection and Drug Resistance
- The cost of antimicrobial resistance
- (2018) Ursula Hofer NATURE REVIEWS MICROBIOLOGY
- The antibiotic pipeline: reviving research and development and speeding drugs to market
- (2017) Katherine H. Luepke et al. Expert Review of Anti-Infective Therapy
- Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens
- (2017) Christoph Lübbert et al. INFECTION
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications
- (2016) Katherine H. Luepke et al. PHARMACOTHERAPY
- When does marketisation lead to privatisation? Profit-making in English health services after the 2012 Health and Social Care Act
- (2015) Nick Krachler et al. SOCIAL SCIENCE & MEDICINE
- How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question
- (2009) T. Fojo et al. JNCI-Journal of the National Cancer Institute
- Objectification, standardization, and commodification in health care: A conceptual readjustment
- (2009) Stefan Timmermans et al. SOCIAL SCIENCE & MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More